Published in Hum Mol Genet on January 22, 2000
The macro domain is an ADP-ribose binding module. EMBO J (2005) 4.07
Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J (2003) 2.94
Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere. Genome Res (2007) 2.03
The 10q25 neocentromere and its inactive progenitor have identical primary nucleotide sequence: further evidence for epigenetic modification. Genome Res (2000) 1.96
PARP-1 and PARP-2: New players in tumour development. Am J Cancer Res (2011) 1.23
Poly(ADP-ribosyl)ation in mammalian ageing. Nucleic Acids Res (2007) 1.13
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol (2004) 1.05
A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells. BMC Cancer (2011) 0.96
PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes. J Biol Chem (2010) 0.95
Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes. Reprod Biol Endocrinol (2009) 0.92
Essential role for poly (ADP-ribosyl)ation in mouse preimplantation development. BMC Mol Biol (2004) 0.87
Persistence of histone H2AX phosphorylation after meiotic chromosome synapsis and abnormal centromere cohesion in poly (ADP-ribose) polymerase (Parp-1) null oocytes. Dev Biol (2009) 0.84
A rapid method of genomic array analysis of scaffold/matrix attachment regions (S/MARs) identifies a 2.5-Mb region of enhanced scaffold/matrix attachment at a human neocentromere. Genome Res (2003) 0.83
Poly(ADP-ribose) polymerase-1 enhances transcription of the profibrotic CCN2 gene. J Am Soc Nephrol (2008) 0.80
Understanding specific functions of PARP-2: new lessons for cancer therapy. Am J Cancer Res (2016) 0.75
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol (2000) 4.27
The gene structure of human anti-haemophilic factor IX. EMBO J (1984) 4.09
Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet (2000) 3.80
Early disruption of centromeric chromatin organization in centromere protein A (Cenpa) null mice. Proc Natl Acad Sci U S A (2000) 3.53
A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nat Genet (1997) 3.36
Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry (2001) 2.97
How practical are recommendations for dietary control in phenylketonuria? Lancet (2002) 2.82
Association between mutations of the follicle-stimulating-hormone receptor and repeated twinning. Lancet (2000) 2.71
Gene deletions in patients with haemophilia B and anti-factor IX antibodies. Nature (1983) 2.59
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet (2001) 2.54
Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev (2000) 2.53
Molecular cloning of the gene for human anti-haemophilic factor IX. Nature (1982) 2.50
The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. Anesth Analg (1999) 2.42
Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest (1993) 2.42
Cardiac myxomas: clinical and echocardiographic profile. Int J Cardiol (1998) 2.38
Determination of the lactose and galactose content of cheese for use in the galactosaemia diet. J Hum Nutr Diet (2009) 2.22
Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet (1994) 2.19
Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res (1992) 2.17
Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency). Lancet (1984) 2.08
Food intolerance and food allergy in children: a review of 68 cases. Arch Dis Child (1982) 2.07
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet (2003) 2.04
A functional marker centromere with no detectable alpha-satellite, satellite III, or CENP-B protein: activation of a latent centromere? Am J Hum Genet (1993) 2.03
Vaginal twin delivery: a survey and review of location, anesthesia coverage and interventions. Int J Obstet Anesth (2007) 2.02
The 10q25 neocentromere and its inactive progenitor have identical primary nucleotide sequence: further evidence for epigenetic modification. Genome Res (2000) 1.96
Comparison of echo and MRI in the imaging evaluation of intracardiac masses. Cardiovasc Intervent Radiol (2004) 1.89
Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci U S A (1993) 1.88
Targeted disruption of mouse centromere protein C gene leads to mitotic disarray and early embryo death. Proc Natl Acad Sci U S A (1998) 1.86
Evidence for the existence of 'atypical' beta-adrenoceptors (beta 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. Br J Pharmacol (1990) 1.84
Achilles tendinopathy: some aspects of basic science and clinical management. Br J Sports Med (2002) 1.84
Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br J Pharmacol (1983) 1.79
Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2. Clin Genet (2008) 1.77
Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J Infect Dis (1985) 1.76
A novel chromatin immunoprecipitation and array (CIA) analysis identifies a 460-kb CENP-A-binding neocentromere DNA. Genome Res (2001) 1.75
Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet (1997) 1.74
Ethylene biosynthesis-inducing protein from cellulysin is an endoxylanase. Plant Physiol (1989) 1.73
Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet (1995) 1.68
Centromere protein B null mice are mitotically and meiotically normal but have lower body and testis weights. J Cell Biol (1998) 1.68
Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet (1994) 1.66
A 330 kb CENP-A binding domain and altered replication timing at a human neocentromere. EMBO J (2001) 1.65
Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol (2000) 1.64
Human centromeres and neocentromeres show identical distribution patterns of >20 functionally important kinetochore-associated proteins. Hum Mol Genet (2000) 1.63
Microorganisms capable of metabolizing the herbicide metolachlor. Appl Environ Microbiol (1987) 1.62
Genetics of the mammalian phenylalanine hydroxylase system. Studies of human liver phenylalanine hydroxylase subunit structure and of mutations in phenylketonuria. Biochem J (1979) 1.61
Defective chromosome segregation, microtubule bundling and nuclear bridging in inner centromere protein gene (Incenp)-disrupted mice. Hum Mol Genet (1999) 1.59
Monosomy 1p36. J Med Genet (1999) 1.58
Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition. Cytogenet Genome Res (2010) 1.54
Football injuries presenting to an accident and emergency department. Health Bull (Edinb) (1987) 1.51
Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition. Cytogenet Genome Res (2013) 1.50
Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet (1995) 1.49
Mouse major (gamma) satellite DNA is highly conserved and organized into extremely long tandem arrays: implications for recombination between nonhomologous chromosomes. Genomics (1989) 1.47
Sequence analysis of an 80 kb human neocentromere. Hum Mol Genet (1999) 1.45
The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child (1986) 1.45
Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann Neurol (1999) 1.45
HZwint-1, a novel human kinetochore component that interacts with HZW10. J Cell Sci (2000) 1.44
What proportion of basic surgical trainees continue in a surgical career? A survey of the factors which are important in influencing career decisions. Surgeon (2009) 1.43
Echocardiographic diagnosis of aneurysm of the sinus of Valsalva. Am Heart J (1993) 1.43
Congenital severe aortic stenosis with congestive heart failure in late childhood and adolescence: effect on left ventricular function after balloon valvuloplasty. Catheter Cardiovasc Interv (2000) 1.43
Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia. Schizophr Res (1998) 1.42
Doppler assessment of interventricular pressure gradient across isolated ventricular septal defect. Clin Cardiol (1990) 1.41
Usefulness of an inexpensive, Paracheck test in detecting asymptomatic infectious reservoir of plasmodium falciparum during dry season in an inaccessible terrain in central India. J Infect (2002) 1.41
Homograft mitral valve replacement: five years' results. J Thorac Cardiovasc Surg (2000) 1.40
Anesthesia in Stevens Johnson syndrome. Indian Pediatr (1989) 1.40
Further sub-classification of alpha-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat [proceedings]. Br J Pharmacol (1979) 1.39
Mitral valve repair in a predominantly rheumatic population. Long-term results. Tex Heart Inst J (2001) 1.39
Effect of the balloon-anulus ratio on the intermediate and follow-up results of pulmonary balloon valvuloplasty. Cardiology (1997) 1.39
Pinning frequencies of the collective modes in alpha-uranium. Phys Rev Lett (2006) 1.39
A simple method of mesorectal transection for carcinoma of upper third of rectum. J R Coll Surg Edinb (2001) 1.38
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38
Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child (1987) 1.38
Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun (2000) 1.38
Heavy cluster knockout reaction (16)O((12)C,2(12)C)(4)He and the nature of the (12)C-(12)C interaction potential. Phys Rev Lett (2011) 1.37
Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion. Am J Med Genet (2000) 1.36
Prevention of anaemia in inner city toddlers by an iron supplemented cows' milk formula. Arch Dis Child (1996) 1.36
Iron supplemented formula milk related to reduction in psychomotor decline in infants from inner city areas: randomised study. BMJ (1999) 1.34
Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor. Br J Pharmacol (1991) 1.33
Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. J Virol (1990) 1.33
Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet (1997) 1.33
Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci U S A (1998) 1.32
Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet (2010) 1.31
Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J Biol Chem (1995) 1.31
The distribution of adrenoceptors and other drug receptors between the two ends of the rat vas deferens as revealed by selective agonists and antagonists. Br J Pharmacol (1980) 1.30
Field evaluation of the ICT malaria P.f/P.v immunochromatographic test for diagnosis of Plasmodium falciparum and P.vivax infection in forest villages of Chhindwara, central India. Trop Med Int Health (2000) 1.29
DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome. Am J Hum Genet (1999) 1.28
Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. J Med Genet (2000) 1.26
The human homologue of the Drosophila melanogaster flightless-I gene (flil) maps within the Smith-Magenis microdeletion critical region in 17p11.2. Am J Hum Genet (1995) 1.26
Further evidence that CENP-C is a necessary component of active centromeres: studies of a dic(X; 15) with simultaneous immunofluorescence and FISH. Hum Mol Genet (1995) 1.26